<DOC>
	<DOCNO>NCT02584439</DOCNO>
	<brief_summary>The conduit arteries exhibit viscoelastic behavior . Visco-elasticity partially regulate endothelium contributes optimization heart-vessel coupling . Aging high rest heart rate ( HR ) could alter visco-elastic property lead increase stiffness conduit artery , independent cardiovascular risk factor , degradation heart-vessel coupling . Lowering HR ivabradine could reduce effect . The objective study assess effect HR reduction repeat administration ivabradine visco-elastic property , vascular geometry function common carotid artery , cardiovascular hemodynamic healthy subject . The influence age ivabradine effect study . 30 healthy volunteer age 25 65 year old , HR ≥ 70 bpm , receive ivabradine placebo 8 day single center , randomize , cross-group , double blind , placebo-controlled study . Each period treatment separate 12 16 day wash-out . Each subject participate exploration visit , include evaluation visco-elastic property , vascular geometry function common carotid artery , cardiovascular hemodynamic , ivabradine placebo taking .</brief_summary>
	<brief_title>Effect Pharmacological Heart Rate Reduction Visco-elastic Properties Arterial Wall ( BRADYVASC )</brief_title>
	<detailed_description />
	<criteria>Healthy volunteer Caucasian Resting heart rate ≥70 bpm ( mean 3 measure 15 minute rest ) No significant EKG abnormality No significant biological abnormality inclusion Healthy volunteer able read understand information letter give write informed consent Healthy volunteer medical insurance Contraception two month woman childbearing age ( Estrogen contraceptive intrauterine device tubal ligation ) ( NB : woman amenorrhea 2 year consider postmenopausal ) Subjects n't understand french language Person deprive liberty administrative judicial decision protect adult subject ( guardianship ) Pregnant woman , nurse mother woman without contraception Healthy volunteer participate trial / participate trial without drug last month trial drug last 3 month Hypersensitivity active substance excipients Congenital galactosemia , lactase deficiency , glucosegalactose malabsorption Body mass index ( BMI ) &lt; 18 kg/m² &gt; 30 kg/m² Severe hypotension ( &lt; 90/50 mmHg ) ( 3 measure 15 minute rest ) Essential secondary Hypertension ( SBP ≥140 mmHg and/or DBP ≥90 mmHg ) ( 3 measure 15 minute rest ) Active smoke day inclusion ( &gt; 5 cigarettes/day ) Severe hypercholesterolemia ( Total cholesterol &gt; 2,5 g/L ) Practice sport intensively ( ≥ 1 hour/day ) Renal insufficiency ( creatinine clearance ≤ 60 ml/min/1,73 m² Cockroft Gault formula ) Known liver failure Known heart failure suspect heart failure ( congestive episode ) Atrial fibrillation Highgrade conduction block ( Sick sinus syndrome , sinoatrial block grade 2 3 atrioventricular block ) Abnormal correct QT Bazett formula ( cQT &gt; 450 m ( men ) &gt; 470 m ( woman ) ) . Pacemaker All cardiac extra cardiac disease , active sequela , , opinion investigator , accompany risk cardiac vascular consequence Retinal disease Taking medication prohibit study except oral contraceptive , acetaminophene decision investigator . In addition , administration drug list schedule 2 previous 4 week prohibit inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ivabradine</keyword>
	<keyword>heart rate</keyword>
	<keyword>age</keyword>
	<keyword>visco-elasticity</keyword>
</DOC>